Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2001-09

AUTHORS

E. T. Lee, H. Keen, P. H. Bennett, J. H. Fuller, M. Lu, and the WHO Multinational Study Group

ABSTRACT

.Aims: The incidence of retinal, renal and cardiovascular complications and their relation to baseline risk factors was documented in this follow-up study of 10 of the 14 original centres of the WHO Multinational Study of Vascular Disease in Diabetes (WHO MSVDD). Methods: The incidence of specified items of vascular disease and some associated risk factors was ascertained after 7 to 9 years (11–12 years in Oklahoma, USA) follow-up, re-using baseline examination methodology in 3165 patients (66.9 %) and, through secondary information in 717 (15.2 %) of the 4729 original patients, of whom 540 (11.4 %) had died and 307 (6.5 %) were untraceable. Results: During follow-up, approximately one third of the patients developed hypertension and one third started insulin. Coronary heart disease incidence varied 10 to 20-fold among centres as did limb amputation rates. Inter-centre differences in incident retinopathy and severe visual impairment were smaller but incident clinical proteinuria and renal failure varied markedly. Vascular disease incidence of all categories was high in Native Americans though coronary heart disease incidence was relatively low in Pima Indians and absolutely low in Hong Kong and Tokyo patients. Specific vascular events and their relation with baseline risk factors are analysed in accompanying papers, summarised in the Epilogue. Conclusion/interpretation: These 10 centres reported very different incidence rates of vascular complications. Observer variation, selection biases and competing causes of mortality contributed to these differences but their validity is supported by the more objective outcome indicators. The following papers also suggest that baseline factors such as raised arterial pressure, cholesterol and fasting glucose (in the centres where it was measured) were important and potentially reversible predictors of risk. [Diabetologia (2001) 44 [Suppl 2]: S 3–S 13] More... »

PAGES

s3

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/pl00002936

DOI

http://dx.doi.org/10.1007/pl00002936

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1012369862

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11587047


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coronary Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetic Angiopathies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetic Nephropathies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetic Retinopathy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Indians, North American", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "International Cooperation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Morbidity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proteinuria", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "World Health Organization", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA", 
          "id": "http://www.grid.ac/institutes/grid.266902.9", 
          "name": [
            "Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "E. T.", 
        "id": "sg:person.015547137254.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015547137254.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Unit for Metabolic Medicine, Guy's Hospital, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.239826.4", 
          "name": [
            "Unit for Metabolic Medicine, Guy's Hospital, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Keen", 
        "givenName": "H.", 
        "id": "sg:person.01042343611.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042343611.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "NIDDK, Phoenix Epidemiology and Clinical Research Branch, Phoenix, Arizona, USA", 
          "id": "http://www.grid.ac/institutes/grid.419635.c", 
          "name": [
            "NIDDK, Phoenix Epidemiology and Clinical Research Branch, Phoenix, Arizona, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bennett", 
        "givenName": "P. H.", 
        "id": "sg:person.011034664412.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011034664412.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "EURODIAB, Department of Epidemiology and Public Health, University College, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.83440.3b", 
          "name": [
            "EURODIAB, Department of Epidemiology and Public Health, University College, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fuller", 
        "givenName": "J. H.", 
        "id": "sg:person.0723231655.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723231655.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA", 
          "id": "http://www.grid.ac/institutes/grid.266902.9", 
          "name": [
            "Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lu", 
        "givenName": "M.", 
        "id": "sg:person.01012305351.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012305351.06"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "and the WHO Multinational Study Group", 
        "id": "sg:person.013726262617.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013726262617.64"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00281119", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035030242", 
          "https://doi.org/10.1007/bf00281119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00274774", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035125558", 
          "https://doi.org/10.1007/bf00274774"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00405109", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022665155", 
          "https://doi.org/10.1007/bf00405109"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-09", 
    "datePublishedReg": "2001-09-01", 
    "description": "Abstract.Aims: The incidence of retinal, renal and cardiovascular complications and their relation to baseline risk factors was documented in this follow-up study of 10 of the 14 original centres of the WHO Multinational Study of Vascular Disease in Diabetes (WHO MSVDD). Methods: The incidence of specified items of vascular disease and some associated risk factors was ascertained after 7 to 9 years (11\u201312 years in Oklahoma, USA) follow-up, re-using baseline examination methodology in 3165 patients (66.9 %) and, through secondary information in 717 (15.2 %) of the 4729 original patients, of whom 540 (11.4 %) had died and 307 (6.5 %) were untraceable. Results: During follow-up, approximately one third of the patients developed hypertension and one third started insulin. Coronary heart disease incidence varied 10 to 20-fold among centres as did limb amputation rates. Inter-centre differences in incident retinopathy and severe visual impairment were smaller but incident clinical proteinuria and renal failure varied markedly. Vascular disease incidence of all categories was high in Native Americans though coronary heart disease incidence was relatively low in Pima Indians and absolutely low in Hong Kong and Tokyo patients. Specific vascular events and their relation with baseline risk factors are analysed in accompanying papers, summarised in the Epilogue. Conclusion/interpretation: These 10 centres reported very different incidence rates of vascular complications. Observer variation, selection biases and competing causes of mortality contributed to these differences but their validity is supported by the more objective outcome indicators. The following papers also suggest that baseline factors such as raised arterial pressure, cholesterol and fasting glucose (in the centres where it was measured) were important and potentially reversible predictors of risk. [Diabetologia (2001) 44 [Suppl 2]: S 3\u2013S 13]", 
    "genre": "article", 
    "id": "sg:pub.10.1007/pl00002936", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2716795", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2428795", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1001482", 
        "issn": [
          "0012-186X", 
          "1432-0428"
        ], 
        "name": "Diabetologia", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "Suppl 2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "44"
      }
    ], 
    "keywords": [
      "coronary heart disease incidence", 
      "WHO Multinational Study", 
      "baseline risk factors", 
      "heart disease incidence", 
      "vascular disease", 
      "risk factors", 
      "multinational study", 
      "limb amputation rate", 
      "severe visual impairment", 
      "cause of mortality", 
      "different incidence rates", 
      "inter-centre differences", 
      "incident retinopathy", 
      "cardiovascular complications", 
      "amputation rate", 
      "clinical proteinuria", 
      "vascular events", 
      "vascular complications", 
      "renal failure", 
      "baseline factors", 
      "arterial pressure", 
      "incidence rate", 
      "original patients", 
      "patients", 
      "disease incidence", 
      "visual impairment", 
      "incidence", 
      "outcome indicators", 
      "Pima Indians", 
      "disease", 
      "complications", 
      "diabetes", 
      "observer variation", 
      "selection biases", 
      "third", 
      "hypertension", 
      "proteinuria", 
      "morbidity", 
      "retinopathy", 
      "factors", 
      "examination methodology", 
      "mortality", 
      "insulin", 
      "cholesterol", 
      "impairment", 
      "center", 
      "study", 
      "differences", 
      "risk", 
      "predictors", 
      "cause", 
      "glucose", 
      "rate", 
      "Native Americans", 
      "failure", 
      "years", 
      "Hong Kong", 
      "Americans", 
      "Indians", 
      "events", 
      "pressure", 
      "original center", 
      "indicators", 
      "items", 
      "categories", 
      "relation", 
      "validity", 
      "Kong", 
      "information", 
      "variation", 
      "biases", 
      "description", 
      "general description", 
      "methodology", 
      "secondary information", 
      "paper", 
      "epilogue"
    ], 
    "name": "Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity", 
    "pagination": "s3", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1012369862"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/pl00002936"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11587047"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/pl00002936", 
      "https://app.dimensions.ai/details/publication/pub.1012369862"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_337.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/pl00002936"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/pl00002936'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/pl00002936'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/pl00002936'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/pl00002936'


 

This table displays all metadata directly associated to this object as RDF triples.

272 TRIPLES      21 PREDICATES      125 URIs      113 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/pl00002936 schema:about N01fd1bfc93c0493ba6028531c861e9d5
2 N04bf577010bb4760b1a73d63ceb085bb
3 N0a857e2806c84d49a3f7685456789e0c
4 N0aa4b36802314a7e978983923d1735bc
5 N2986933952e44ad5aabc48b55fb03415
6 N46b99350b0b34b4695556653f32fb9e9
7 N4a49ed076a4d47b49dd584e5184a7ff3
8 N4a4a6df3326445dc8d159c72983687fa
9 N4c94fdbd869e47a4ae27575217d67dee
10 N5c22ff57d0de44709d4285b790c054b0
11 N734b7927412044af89ca7118a066bb71
12 N89d0d9f63e4b4624885b42ba67c1db07
13 Na12341285c1245539bfd661c3ff8a097
14 Nae164f5435074697bcd5d97cdd603968
15 Nd64946eb895e47ee9e483fa871f0b0c8
16 Nde2097e932ba436299d601dabf7c4ce4
17 Ne35d1d2495cd4273be2523cac89757fe
18 Nebd05cc4abd240f797ecd4d9dbe340b2
19 anzsrc-for:11
20 anzsrc-for:1102
21 anzsrc-for:1117
22 schema:author N666e1cea1d594f7088c56d8be5631df0
23 schema:citation sg:pub.10.1007/bf00274774
24 sg:pub.10.1007/bf00281119
25 sg:pub.10.1007/bf00405109
26 schema:datePublished 2001-09
27 schema:datePublishedReg 2001-09-01
28 schema:description Abstract.Aims: The incidence of retinal, renal and cardiovascular complications and their relation to baseline risk factors was documented in this follow-up study of 10 of the 14 original centres of the WHO Multinational Study of Vascular Disease in Diabetes (WHO MSVDD). Methods: The incidence of specified items of vascular disease and some associated risk factors was ascertained after 7 to 9 years (11–12 years in Oklahoma, USA) follow-up, re-using baseline examination methodology in 3165 patients (66.9 %) and, through secondary information in 717 (15.2 %) of the 4729 original patients, of whom 540 (11.4 %) had died and 307 (6.5 %) were untraceable. Results: During follow-up, approximately one third of the patients developed hypertension and one third started insulin. Coronary heart disease incidence varied 10 to 20-fold among centres as did limb amputation rates. Inter-centre differences in incident retinopathy and severe visual impairment were smaller but incident clinical proteinuria and renal failure varied markedly. Vascular disease incidence of all categories was high in Native Americans though coronary heart disease incidence was relatively low in Pima Indians and absolutely low in Hong Kong and Tokyo patients. Specific vascular events and their relation with baseline risk factors are analysed in accompanying papers, summarised in the Epilogue. Conclusion/interpretation: These 10 centres reported very different incidence rates of vascular complications. Observer variation, selection biases and competing causes of mortality contributed to these differences but their validity is supported by the more objective outcome indicators. The following papers also suggest that baseline factors such as raised arterial pressure, cholesterol and fasting glucose (in the centres where it was measured) were important and potentially reversible predictors of risk. [Diabetologia (2001) 44 [Suppl 2]: S 3–S 13]
29 schema:genre article
30 schema:isAccessibleForFree true
31 schema:isPartOf N8768dbe1c89b4e93b1f345cc59d32cc0
32 Na0c865b1d9654e7f80c3f4b375b5b85b
33 sg:journal.1001482
34 schema:keywords Americans
35 Hong Kong
36 Indians
37 Kong
38 Native Americans
39 Pima Indians
40 WHO Multinational Study
41 amputation rate
42 arterial pressure
43 baseline factors
44 baseline risk factors
45 biases
46 cardiovascular complications
47 categories
48 cause
49 cause of mortality
50 center
51 cholesterol
52 clinical proteinuria
53 complications
54 coronary heart disease incidence
55 description
56 diabetes
57 differences
58 different incidence rates
59 disease
60 disease incidence
61 epilogue
62 events
63 examination methodology
64 factors
65 failure
66 general description
67 glucose
68 heart disease incidence
69 hypertension
70 impairment
71 incidence
72 incidence rate
73 incident retinopathy
74 indicators
75 information
76 insulin
77 inter-centre differences
78 items
79 limb amputation rate
80 methodology
81 morbidity
82 mortality
83 multinational study
84 observer variation
85 original center
86 original patients
87 outcome indicators
88 paper
89 patients
90 predictors
91 pressure
92 proteinuria
93 rate
94 relation
95 renal failure
96 retinopathy
97 risk
98 risk factors
99 secondary information
100 selection biases
101 severe visual impairment
102 study
103 third
104 validity
105 variation
106 vascular complications
107 vascular disease
108 vascular events
109 visual impairment
110 years
111 schema:name Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity
112 schema:pagination s3
113 schema:productId N53fe10d902e848639218ee9ed9a6aba8
114 Nb31af78045254ba088316c8aaa992755
115 Nb372ce60ae574fb39b74f6ea3c6465b1
116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012369862
117 https://doi.org/10.1007/pl00002936
118 schema:sdDatePublished 2022-12-01T06:23
119 schema:sdLicense https://scigraph.springernature.com/explorer/license/
120 schema:sdPublisher Naf629116f596495c9cfeb86aac42100e
121 schema:url https://doi.org/10.1007/pl00002936
122 sgo:license sg:explorer/license/
123 sgo:sdDataset articles
124 rdf:type schema:ScholarlyArticle
125 N01fd1bfc93c0493ba6028531c861e9d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Proteinuria
127 rdf:type schema:DefinedTerm
128 N04bf577010bb4760b1a73d63ceb085bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Adult
130 rdf:type schema:DefinedTerm
131 N0a857e2806c84d49a3f7685456789e0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Diabetic Angiopathies
133 rdf:type schema:DefinedTerm
134 N0aa4b36802314a7e978983923d1735bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Middle Aged
136 rdf:type schema:DefinedTerm
137 N13c6573d04b74e258b284976ba75ed3f rdf:first sg:person.01012305351.06
138 rdf:rest Ne777faf4b9ec45318193b782a748e146
139 N2986933952e44ad5aabc48b55fb03415 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Coronary Disease
141 rdf:type schema:DefinedTerm
142 N44944900ed1141f9a5bfd23f74959d73 rdf:first sg:person.011034664412.40
143 rdf:rest Nd896baa7a795410e814ef2d5df05b9ee
144 N46b99350b0b34b4695556653f32fb9e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Hypertension
146 rdf:type schema:DefinedTerm
147 N4a49ed076a4d47b49dd584e5184a7ff3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name World Health Organization
149 rdf:type schema:DefinedTerm
150 N4a4a6df3326445dc8d159c72983687fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Female
152 rdf:type schema:DefinedTerm
153 N4c94fdbd869e47a4ae27575217d67dee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Diabetic Retinopathy
155 rdf:type schema:DefinedTerm
156 N53fe10d902e848639218ee9ed9a6aba8 schema:name doi
157 schema:value 10.1007/pl00002936
158 rdf:type schema:PropertyValue
159 N5c22ff57d0de44709d4285b790c054b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Diabetes Mellitus, Type 2
161 rdf:type schema:DefinedTerm
162 N604428c9635e4a0489f8a1a030af58b9 rdf:first sg:person.01042343611.09
163 rdf:rest N44944900ed1141f9a5bfd23f74959d73
164 N666e1cea1d594f7088c56d8be5631df0 rdf:first sg:person.015547137254.79
165 rdf:rest N604428c9635e4a0489f8a1a030af58b9
166 N734b7927412044af89ca7118a066bb71 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Male
168 rdf:type schema:DefinedTerm
169 N8768dbe1c89b4e93b1f345cc59d32cc0 schema:issueNumber Suppl 2
170 rdf:type schema:PublicationIssue
171 N89d0d9f63e4b4624885b42ba67c1db07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name International Cooperation
173 rdf:type schema:DefinedTerm
174 Na0c865b1d9654e7f80c3f4b375b5b85b schema:volumeNumber 44
175 rdf:type schema:PublicationVolume
176 Na12341285c1245539bfd661c3ff8a097 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Indians, North American
178 rdf:type schema:DefinedTerm
179 Nae164f5435074697bcd5d97cdd603968 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Diabetic Nephropathies
181 rdf:type schema:DefinedTerm
182 Naf629116f596495c9cfeb86aac42100e schema:name Springer Nature - SN SciGraph project
183 rdf:type schema:Organization
184 Nb31af78045254ba088316c8aaa992755 schema:name pubmed_id
185 schema:value 11587047
186 rdf:type schema:PropertyValue
187 Nb372ce60ae574fb39b74f6ea3c6465b1 schema:name dimensions_id
188 schema:value pub.1012369862
189 rdf:type schema:PropertyValue
190 Nd64946eb895e47ee9e483fa871f0b0c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Morbidity
192 rdf:type schema:DefinedTerm
193 Nd896baa7a795410e814ef2d5df05b9ee rdf:first sg:person.0723231655.42
194 rdf:rest N13c6573d04b74e258b284976ba75ed3f
195 Nde2097e932ba436299d601dabf7c4ce4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Risk Factors
197 rdf:type schema:DefinedTerm
198 Ne35d1d2495cd4273be2523cac89757fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Diabetes Mellitus, Type 1
200 rdf:type schema:DefinedTerm
201 Ne777faf4b9ec45318193b782a748e146 rdf:first sg:person.013726262617.64
202 rdf:rest rdf:nil
203 Nebd05cc4abd240f797ecd4d9dbe340b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Humans
205 rdf:type schema:DefinedTerm
206 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
207 schema:name Medical and Health Sciences
208 rdf:type schema:DefinedTerm
209 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
210 schema:name Cardiorespiratory Medicine and Haematology
211 rdf:type schema:DefinedTerm
212 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
213 schema:name Public Health and Health Services
214 rdf:type schema:DefinedTerm
215 sg:grant.2428795 http://pending.schema.org/fundedItem sg:pub.10.1007/pl00002936
216 rdf:type schema:MonetaryGrant
217 sg:grant.2716795 http://pending.schema.org/fundedItem sg:pub.10.1007/pl00002936
218 rdf:type schema:MonetaryGrant
219 sg:journal.1001482 schema:issn 0012-186X
220 1432-0428
221 schema:name Diabetologia
222 schema:publisher Springer Nature
223 rdf:type schema:Periodical
224 sg:person.01012305351.06 schema:affiliation grid-institutes:grid.266902.9
225 schema:familyName Lu
226 schema:givenName M.
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012305351.06
228 rdf:type schema:Person
229 sg:person.01042343611.09 schema:affiliation grid-institutes:grid.239826.4
230 schema:familyName Keen
231 schema:givenName H.
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042343611.09
233 rdf:type schema:Person
234 sg:person.011034664412.40 schema:affiliation grid-institutes:grid.419635.c
235 schema:familyName Bennett
236 schema:givenName P. H.
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011034664412.40
238 rdf:type schema:Person
239 sg:person.013726262617.64 schema:familyName and the WHO Multinational Study Group
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013726262617.64
241 rdf:type schema:Person
242 sg:person.015547137254.79 schema:affiliation grid-institutes:grid.266902.9
243 schema:familyName Lee
244 schema:givenName E. T.
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015547137254.79
246 rdf:type schema:Person
247 sg:person.0723231655.42 schema:affiliation grid-institutes:grid.83440.3b
248 schema:familyName Fuller
249 schema:givenName J. H.
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723231655.42
251 rdf:type schema:Person
252 sg:pub.10.1007/bf00274774 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035125558
253 https://doi.org/10.1007/bf00274774
254 rdf:type schema:CreativeWork
255 sg:pub.10.1007/bf00281119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035030242
256 https://doi.org/10.1007/bf00281119
257 rdf:type schema:CreativeWork
258 sg:pub.10.1007/bf00405109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022665155
259 https://doi.org/10.1007/bf00405109
260 rdf:type schema:CreativeWork
261 grid-institutes:grid.239826.4 schema:alternateName Unit for Metabolic Medicine, Guy's Hospital, London, UK
262 schema:name Unit for Metabolic Medicine, Guy's Hospital, London, UK
263 rdf:type schema:Organization
264 grid-institutes:grid.266902.9 schema:alternateName Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA
265 schema:name Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA
266 rdf:type schema:Organization
267 grid-institutes:grid.419635.c schema:alternateName NIDDK, Phoenix Epidemiology and Clinical Research Branch, Phoenix, Arizona, USA
268 schema:name NIDDK, Phoenix Epidemiology and Clinical Research Branch, Phoenix, Arizona, USA
269 rdf:type schema:Organization
270 grid-institutes:grid.83440.3b schema:alternateName EURODIAB, Department of Epidemiology and Public Health, University College, London, UK
271 schema:name EURODIAB, Department of Epidemiology and Public Health, University College, London, UK
272 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...